Loading events...
The clinical trials landscape is reaching a critical juncture. Mounting pressure to accelerate timelines, reduce costs, and enhance patient experience converges with breakthrough innovations: agentic AI, decentralised trials, and digital biomarkers as qualifying endpoints . Yet implementation remains fragmented. Industry leaders require bold, integrated digital strategies that eliminate silos, deploy end-to-end technologies, and embed patient-centricity throughout trial design and execution.
Tuesday, January 27, 2026
London, UK
The clinical trials landscape is reaching a critical juncture. Mounting pressure to accelerate timelines, reduce costs, and enhance patient experience converges with breakthrough innovations: agentic AI, decentralised trials, and digital biomarkers as qualifying endpoints . Yet implementation remains fragmented. Industry leaders require bold, integrated digital strategies that eliminate silos, deploy end-to-end technologies, and embed patient-centricity throughout trial design and execution.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox